SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Neurorehabilitation and Neural Repair
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Herman, R.
Right arrow Articles by D'Luzansky, S. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Herman, R.
Right arrow Articles by D'Luzansky, S. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pharmacologic Management of Spinal Spasticity

Richard Herman

Samaritan Rehabilitation Institute, Phoenix, AZ, Department of Pharmacology, University of. Arizona Health Sciences Center, Tucson, AZ

Stephen C. D'Luzansky

Samaritan Rehabilitation Institute, Phoenix, AZ

Pharmacologic management of spasticity of spinal origin is determined in part by several factors: 1) evidence of a spasticity-related dysfunctional profile, 2) acknowledgement of the clinical effectiveness and side effects of commonly utilized pharmacologic agents, 3) pathophysiologic mechanisms and spinal plasticity (neuronal excitability, anatomical and biochemical reorganization), 4) pharmacokinetics and subject compliance, and 5) unique methods of drug administration. Presently, preferred agents include systemically administered substances, which presumably act at the level of segmental and intersegmental interneuronal circuitry-e.g. baclofen or clonidine, and at the level of muscle contractile tissue-e.g. dantrolene sodium. This paper also describes the action of intrathecally administered morphine on spinal spasticity in subjects resistant to the action of oral agents.

Key Words: Keywords: Spinal spasticity • intrathecal infusion • pharmacotherapy • spinal reflexes.

Neurorehabilitation and Neural Repair, Vol. 5, No. 5 suppl, S15-S20 (1991)
DOI: 10.1177/136140969100500504
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement